Navy General Hospital, Beijing
Clinical trials sponsored by Navy General Hospital, Beijing, explained in plain language.
-
New hope for Tough-to-Treat blood cancer patients
Disease control Not yet recruitingThis study is testing whether a combination of three drugs (glofitamab, polatuzumab vedotin, and GemOx) can help control aggressive B-cell lymphoma that has returned or hasn't responded to previous treatment. The trial will enroll 80 adults to see how well the treatment works and…
Phase: PHASE2 • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Smartwatches track heart rhythm to predict stroke danger
Knowledge-focused Not yet recruitingThis large observational study aims to understand the link between the amount of time a person spends in atrial fibrillation (AF) and their risk of having a stroke. It will follow 10,000 people with AF for two years, using their own smartwatches to monitor their heart rhythms, bu…
Sponsor: Navy General Hospital, Beijing • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC